Incyte is a biopharmaceutical company based in the United States that discovers, develops and commercialises medicines for cancer and inflammatory conditions. Its products include treatments for rare blood cancers and a topical medicine for skin conditions, sold mainly to specialist physicians and hospitals. The company also runs a portfolio of clinical programmes in oncology and immune disorders, and earns royalty revenue from partners who market some of its medicines outside its home market.
The shares are listed on the London Exchange in UK under the code 0J9P, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1061 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
71/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average5.8%
From 52-week high-12.6%
MomentumFair
69/100
Typical recent returns for this exchange.
See the numbers →
3-month return-3.1%
6-month return16.4%
12-month, skipping last month48.0%
Stability (higher is calmer)Fair
66/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)33.0%
Worst drawdown, 1 year (smaller is calmer)-18.3%
LiquidityWeak
38/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.23M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 83.00 – 134.99Daily closes, split-adjusted
Signals
50-day average121.93
200-day average107.50
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.05
Technical summary
Daily
Bearish
3 bullish · 4 neutral · 9 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
112.7
Bullish
EMA 10
113.8
Bearish
SMA 20
117.8
Bearish
EMA 20
116.5
Bearish
SMA 50
121.9
Bearish
EMA 50
118.7
Bearish
SMA 100
116.3
Bearish
EMA 100
115.8
Bearish
SMA 200
107.5
Bullish
EMA 200
108.6
Bullish
Oscillators (daily)
RSI (14)
40.60
Neutral
MACD (12, 26)
-3.14
Bearish
Momentum (12)
-7.54
Bearish
Stochastic %K (14)
35.29
Neutral
Williams %R (14)
-64.71
Neutral
CCI (20)
-55.20
Neutral
Pivot points (classic, last session)
S3
106.4
S2
108.7
S1
111.2
Pivot
113.6
R1
116.1
R2
118.5
R3
121.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
